Charles River Laboratories Operating Margin 2010-2025 | CRL

Current and historical operating margin for Charles River Laboratories (CRL) over the last 10 years. The current operating profit margin for Charles River Laboratories as of March 31, 2025 is 13.39%.
Charles River Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $4.02B $0.18B 4.37%
2024-12-31 $4.05B $0.23B 5.60%
2024-09-30 $4.06B $0.53B 13.00%
2024-06-30 $4.08B $0.56B 13.81%
2024-03-31 $4.11B $0.58B 14.01%
2023-12-31 $4.13B $0.62B 14.97%
2023-09-30 $4.22B $0.65B 15.39%
2023-06-30 $4.18B $0.65B 15.51%
2023-03-31 $4.09B $0.67B 16.38%
2022-12-31 $3.98B $0.65B 16.37%
2022-09-30 $3.78B $0.66B 17.46%
2022-06-30 $3.69B $0.67B 18.03%
2022-03-31 $3.63B $0.62B 16.97%
2021-12-31 $3.54B $0.59B 16.69%
2021-09-30 $3.43B $0.55B 15.96%
2021-06-30 $3.27B $0.52B 16.00%
2021-03-31 $3.04B $0.46B 15.22%
2020-12-31 $2.92B $0.43B 14.81%
2020-09-30 $2.82B $0.41B 14.62%
2020-06-30 $2.75B $0.37B 13.57%
2020-03-31 $2.72B $0.38B 13.80%
2019-12-31 $2.62B $0.35B 13.42%
2019-09-30 $2.53B $0.35B 13.62%
2019-06-30 $2.45B $0.34B 13.71%
2019-03-31 $2.38B $0.33B 14.01%
2018-12-31 $2.27B $0.33B 14.61%
2018-09-30 $2.14B $0.29B 13.63%
2018-06-30 $2.02B $0.28B 13.95%
2018-03-31 $1.91B $0.29B 15.07%
2017-12-31 $1.86B $0.29B 15.56%
2017-09-30 $1.85B $0.30B 15.98%
2017-06-30 $1.81B $0.28B 15.49%
2017-03-31 $1.77B $0.26B 14.44%
2016-12-31 $1.68B $0.24B 14.09%
2016-09-30 $1.57B $0.22B 14.02%
2016-06-30 $1.49B $0.22B 14.48%
2016-03-31 $1.40B $0.21B 15.31%
2015-12-31 $1.36B $0.21B 15.11%
2015-09-30 $1.34B $0.20B 14.56%
2015-06-30 $1.32B $0.19B 14.11%
2015-03-31 $1.32B $0.18B 13.72%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.89%
2014-06-30 $1.22B $0.16B 12.86%
2014-03-31 $1.17B $0.15B 12.70%
2013-12-31 $1.17B $0.15B 13.05%
2013-09-30 $1.16B $0.16B 14.01%
2013-06-30 $1.14B $0.16B 13.91%
2013-03-31 $1.14B $0.17B 14.54%
2012-12-31 $1.13B $0.17B 14.69%
2012-09-30 $1.14B $0.17B 15.16%
2012-06-30 $1.14B $0.17B 15.09%
2012-03-31 $1.14B $0.18B 15.40%
2011-12-31 $1.14B $0.17B 15.22%
2011-09-30 $1.13B $-0.23B -20.55%
2011-06-30 $1.13B $-0.26B -23.43%
2011-03-31 $1.13B $-0.29B -25.44%
2010-12-31 $1.13B $-0.30B -26.37%
2010-09-30 $1.12B $0.10B 9.05%
2010-06-30 $1.14B $0.14B 12.17%
2010-03-31 $1.16B $0.16B 13.78%
2009-12-31 $1.17B $0.17B 14.52%
Sector Industry Market Cap Revenue
Medical Medical Services $6.944B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.565B 26.36
Elevance Health (ELV) United States $91.235B 11.77
CVS Health (CVS) United States $79.418B 9.87
Cencora (COR) United States $56.719B 19.73
DiDi Global (DIDIY) China $21.932B 33.29
Natera (NTRA) United States $20.928B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $13.109B 13.88
EUROFINS SCIENT (ERFSF) Luxembourg $11.943B 0.00
CochLear (CHEOY) Australia $11.734B 0.00
Revvity (RVTY) United States $11.115B 19.13
ICON (ICLR) Ireland $10.559B 9.82
Viatris (VTRS) United States $10.281B 3.53
Doximity (DOCS) United States $10.038B 46.76
Avantor (AVTR) United States $9.104B 13.23
Medpace Holdings (MEDP) United States $8.794B 23.36
HealthEquity (HQY) United States $8.442B 41.53
Sonic Healthcare (SKHHY) Australia $8.311B 0.00
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.201B 38.89
Bausch + Lomb (BLCO) Canada $4.160B 24.52
Sotera Health (SHC) United States $3.616B 20.55
Alignment Healthcare (ALHC) United States $3.213B 0.00
Surgery Partners (SGRY) United States $3.025B 39.33
Concentras Parent (CON) United States $2.892B 16.71
Organon (OGN) United States $2.340B 2.49
Ardent Health Partners (ARDT) United States $2.167B 9.24
GeneDx Holdings (WGS) United States $2.026B 78.04
Premier (PINC) United States $1.903B 14.44
Progyny (PGNY) United States $1.843B 40.57
PACS (PACS) United States $1.623B 0.00
GoodRx Holdings (GDRX) United States $1.411B 28.21
Teladoc Health (TDOC) United States $1.282B 0.00
Pediatrix Medical (MD) United States $1.277B 9.72
Establishment Labs Holdings (ESTA) $1.065B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.986B 15.39
Nutex Health (NUTX) United States $0.981B 14.82
Agilon Health (AGL) United States $0.969B 0.00
AMN Healthcare Services Inc (AMN) United States $0.858B 8.04
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.679B 4.57
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.38
Auna S.A (AUNA) Luxembourg $0.524B 13.88
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.481B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.404B 0.00
SBC Medicals (SBC) United States $0.353B 0.00
Oncology Institute (TOI) United States $0.231B 0.00
Performant Healthcare (PHLT) United States $0.211B 0.00
Beauty Health (SKIN) United States $0.205B 0.00
DocGo (DCGO) United States $0.148B 24.17
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
KindlyMD (KDLY) United States $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Pheton Holdings (PTHL) China $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00